PRA_StandardLogo_RGB_Pink.png
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma
May 13, 2021 16:02 ET | PRA Health Sciences, Inc.
RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows...
Certara-CMYK-01.jpg
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
May 13, 2021 08:00 ET | Certara
PRINCETON, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of new versions of its Immunogenicity (IG) and...
Innovation Pharma Files Form 10-Q; Patient Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19 Tops 70 Percent
May 13, 2021 08:00 ET | Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces the filing of its SEC Form...
logo-med.png
CrannMed partners with leading Digital Research Organization, Meditrial to obtain “Breakthrough Device Designation” by the FDA for its innovative Knee Osteoarthritis Therapy
May 13, 2021 06:00 ET | Meditrial
NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- Meditrial Inc, a leading Global Digitally Driven Research Organization, is pleased to announce its successful collaboration with CrannMed Limited in...
22157.jpg
Global Clinical Trials Markets, 2016-2020 & 2021-2026 - Digitization of Clinical Trials is Anticipated to Propel the Growth
May 11, 2021 05:08 ET | Research and Markets
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Market, By Type (Pharmaceutical Trials Vs Medical Device Trials), By Phase (Phase I, Phase II, Phase III, Phase IV), By Study...
RYAH logo.jpg
RYAH Group, Inc. Enters New Zealand Market, signs Distribution Agreement with Medical Kiwi Ltd
May 10, 2021 09:29 ET | Potbotics, Inc. o/a RYAH
New York, May 10, 2021 (GLOBE NEWSWIRE) -- via InvestorWire-- RYAH Group, Inc’s (CSE:RYAH) wholly owned subsidiary, RYAH Medtech, Inc., a medical device, data and technology company announced today...
Vineti.JPG
Vineti Introduces PTM Essentials™ to Accelerate Cell and Gene Therapy Clinical Trials with a New Digital Supply Chain Solution
May 10, 2021 07:00 ET | Vineti
New PTM Essentials™ solution draws on Vineti’s industry-leading Personalized Therapy Management® (PTM) software platform to deliver breakthrough speed and simplicity for advanced therapy clinical...
22157.jpg
Worldwide Peptide Cancer Vaccine Industry to 2026 - 90 Peptide Vaccines in Pipeline with Market Opportunity Value of >$20 Billion
May 07, 2021 06:38 ET | Research and Markets
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Global Peptide Cancer Vaccine Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. As per this...
22157.jpg
Worldwide Clinical Trials Industry to 2026 - Players Include Aptiv Solutions, ICON and Medpace Among Others
May 06, 2021 06:28 ET | Research and Markets
Dublin, May 06, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Market (2021-2026) by Study Phases, Study Designs, Indication of Disease, Geography and the Impact of COVID-19 with Ansoff...
peptomyc-color-pos.png
PEPTOMYC SL Announces Treatment of First Patient with its Lead Compound OMO-103 in a Phase I/II Clinical Trial
May 06, 2021 03:30 ET | Peptomyc S.L.
BARCELONA, Spain, May 06, 2021 (GLOBE NEWSWIRE) -- Peptomyc, a Spanish clinical stage biotech company spin-off of the Vall d’Hebron Institute of Oncology (VHIO) and the Catalan Institute of Research...